Protein and lipid kinases are known to play key roles in maintaining cellular health. Disruption in kinase signaling cascades can lead to a host of diseases and conditions, including diabetes, cancer, Alzheimer's disease, and bipolar disorder. A subset of kinases requires an activating phosphorylation within a region of their catalytic domains known as the activation loop to achieve maximum enzymatic activity. While this can be mediated via an upstream kinase, often it is the result of an autophosphorylation event, which sets up the paradoxical question of how the first kinase becomes phosphorylated. Recently, mechanisms for this first autophosphorylation have been elucidated for a handful of kinases and they broadly fall into two categories: cis-autophosphorylation, where a translational intermediate has distinct kinase activity or trans-autophosphorylation, where two kinase domains come together to facilitate phosphoryl transfer. At a time when kinase inhibition holds tremendous promise for drug therapies but high specificity is paramount, these mechanisms that underpin the very way kinases are activated may hold the key to the development of new specific inhibitors for both laboratory work focusing on discrete kinases and therapeutics for disease treatment.
Introduction
Signaling pathways involving cell growth, differentiation, proliferation, apoptosis, and metabolism are governed in large part by the reversible phosphorylation of proteins (Matthews and Gerritsen, 2010) . A protein's phosphorylation state, and thus its activity, is dependent upon both the kinases and phosphatases that act upon it (Alberts, 2002) . Phosphate groups are rapidly turned over allowing for quick changes between a protein's active and inactive states and such swift modifications are necessary for cells to respond efficiently to stimuli (Alberts, 2002) . Mutations in kinases are known to disrupt cell signaling events and have been implicated in diabetes and cancer as well as disorders in cardiovascular health, neurodegeneration, development, and behavior (Lahiry et al., 2010) , thus kinases play key roles in maintaining cellular health (Duong-Ly and Peterson, 2012; Zhang et al., 2009 ). Because of this, these enzymes have become important chemotherapeutic targets with notable success stories involving the tyrosine kinase inhibitors imatinib mesylate (Gleevec, Novartis), gefitinib (Iressa), and erlotinib (Tarceva), which all demonstrate antitumor activity (Arora and Scholar, 2005). Unfortunately, most inhibitors work by targeting the highly conserved ATPbinding pocket, which can result in reduced specificity and off-target effects. In addition, many kinases in the human kinome, including several that are clinically relevant, lack validated inhibitors that would be beneficial to both the medical world needing therapeutics and laboratory work seeking to understand kinase function (Anastassiadis et al., 2011; Fedorov et al., 2007) . Given the high profile nature of kinases in disease, new and insightful inhibitor strategies are necessary (Duong-Ly and Peterson, 2012).
Phosphorylation is the enzyme-catalyzed transfer of the gamma phosphate from either ATP or GTP to the side chain hydroxyl group of a substrate protein's serine, threonine or tyrosine or to a lipid head group (Alberts, 2002) . The kinase domain is responsible for binding nucleotide, phosphate acceptor, and the required cofactor Mg2+ as well as facilitating phosphate transfer and eventual release of products. This process is unidirectional due to the large amount of free energy that is released upon ATP/GTP hydrolysis (Alberts, 2002) . The ePK domain is comprised of 250 amino acids that form the N terminal and C terminal lobes (N-lobe and C-lobe respectively), which are connected by a hinge region (Alberts, 2002; DuongLy and Peterson, 2012) . The N-lobe is smaller and has a mixture of alpha helices, including the notable C helix, and several beta strands while the larger C-lobe is composed primarily of alpha helices (Duong-Ly and Peterson, 2012) ( Figures  1A and B) . The highly conserved ATP binding pocket sits in the cleft between the lobes while the C lobe is primarily responsible for interacting with the substrate ( Figure 1C ). All protein kinases have a strictly conserved aspartate residue that is critical for catalysis (D389 in Pak1, (Johnson et al., 1996) ). Kinases that have an asparagine residue (R) immediately preceding the catalytic aspartate (D) are common amongst most serine/threonine kinases and all tyrosine kinases and are known as RD kinases (Johnson et al., 1996) .
Because correct spatial and temporal control of phosphorylation is necessary, kinases have adopted several different regulatory mechanisms to control their catalytic activity. Some kinases need to complex with other subunits that are under strict transcriptional control before reaching full catalytic activity. This type of regulation is most common among cyclin-dependent kinases (CDKs), which form heterodimeric complexes with cyclin proteins, whose concentrations change during the cell cycle (Johnson et al., 1996; Lodish et al., 2004) . Requiring the binding of secondary messengers such as cyclic AMP (cAMP), diacylglycerol, or Ca2+/calmodulin to cAMP-dependent kinase, protein kinase C or calmodulin-dependent kinase, respectively, is another type of regulation (Johnson et al., 1996) . Other kinases, such as Pak1, require correct localization via multivalent basic motifs before becoming active, but others will use pleckstrin homology (PH) domains or SH3 domains (Johnson Kimberly A. Malecka et al., 1996; Strochlic et al., 2010) . The final and best understood mechanism for activation is through the phosphorylation of the kinase itself. It became apparent through research in the late 20th century that phosphorylation of key residues within an area alternatively called the activation segment, the activation loop or the T-loop were essential to obtain full catalytic activity for a particular subset of kinases (Johnson et al., 1996; Nolen et al., 2004) . In fact, Johnson et al. declared that "…control by phosphorylation in the activation segment is a property of most, but not all, protein kinases." (Johnson et al., 1996) .
In the early 1980s, autophosphorylation of Y416 in pp60v-src was observed and it was then demonstrated that this phosphorylation event was significant for controlling the activity of the cellular Src kinase (Hunter, 1987) . Currently, a substantial number of kinases, particularly RD kinases, are known to require a phosphorylation within the activation loop to achieve full activity (Oliver et al., 2007) . A comparison of catalytic domains from several different kinases in the active state shows that their conformations are highly conserved. When phosphorylated, the activation loop, defined as the approximately thirty amino acids that span between the conserved DFG (aspartate-phenylalanine-glycine) and APE (alanine-proline-glutamine) motifs, pulls away from the active site and is held in place by an extensive charge network (Lei et al., 2005; Lowe et al., 19997; Zhou et al., 2004) . The strictly conserved aspartate residue (D389 in Pak1), which is part of the DFG motif, coordinates with an Mg2+ ion to position the phosphate groups of ATP for phosphoryl transfer (Duong-Ly and Peterson, 2012). Additionally, the DFG group is typically found pointing towards the ATP binding site in active kinase states; this conformation is called DFG-in. In contrast to their active states, inactive kinase conformations vary widely. For example, the activation loop of Pak1 is disordered in the crystal structure indicating its lack of fixed position ( Figure 1A ). Pak1 is an autoinhibited kinase due to its N-terminal regulatory domain, which occupies the active site and prohibits substrate binding (Lei et al., 2000) . In most inactive kinase states, the DFG motif's aspartate residue is pointing away from the ATP binding site and referred to as DFG-out. However, many kinases are known to phosphorylate their own activation loops and beg the question of how the kinases resolve this contradiction.
Accumulating structural and biochemical data for various kinases reveal novel molecular mechanisms for how this first phosphorylation can occur: posttranslational transient folding intermediates can lead to cis-autophosphorylation while dimeric or multi-protein complexes allow for transautophosphorylation.
These revelations are changing the way we look and think about kinase activity. First, a kinase-substrate relationship involves more distal areas from the enzyme's active site residues and the substrate's few amino acids held in the binding pocket. Second, and perhaps more exciting, the fact that these autophosphorylation events underpin the kinases' very ability to mediate their own activation in addition the activation of their substrates and that this autophosphorylation event can occur through several different mechanisms, a new avenue is being paved that could lead to more kinase-specific inhibitors.
Cis-autophosphorylation
The serine-threonine kinase glycogen synthase kinase 3 (GSK3) plays a role in cell fate, cell division, apoptosis and gluconeogenesis (Cohen Using a similar mechanism, the homeodomaininteracting protein kinase 2 (HIPK2), another member of the CMGC family and a close relation to DYRKs, was also found to cis-autophosphorylate its activation loop residues Y354 and S357 to achieve kinase activity (Saul et al., 2012) . Of the four HIPK family members, HIPK2 is the most studied and is known to regulate cell proliferation, play a functional role in cancer, as well as an extremely large number of signaling pathways including DNA damage response, p53 activation and Hedgehog signaling (Saul et al., 2012) .
Other kinases are speculated to undergo cisauthophosphorylation. ERK7 (extracellular signal regulated kinase 7) is a member of the MAPK family, which require phosphorlyation of either tyrosine or threonine in their activation loops for activity (Abe et al., 2001 ). Unlike other ERKs, ERK7 is constitutively active and its catalytic activity fails to further increase when other MAPKs are activated (Abe et al., 2001) . Competition experiments with the catalytically dead K43R ERK7 indicates that autophosphorylation is an intramolecular event and an ERK7 C terminal deletion mutant fails to phosphorylate its activation loop or become catalytically active (Abe et al., 1999) . Together, these results suggest that ERK7 may activate itself in a mechanism similar to those described for GSK3β, dDYRK2 and MNB, thus introducing a new and novel class of MAPK family members (Abe et al., 2001 ). cAMP-activated protein kinase (PKA) is another candidate. The kinase is phosphorylated at T197 within its activation loop and a T197A mutant has virtually no activity in cells (Huggenvik The mechanism of cis-autophosphorylation provides a necessary and key event to yield an active kinase, but has both positive and negative consequences. The kinase is able to form a translational intermediate capable of phosphorylating itself, thus describing an independent event that does not rely on any other kinase.
However, phosphatase treatment of these kinases shows that these cis-autophosphorylations are difficult to remove indicating that they most likely become buried in the final protein conformation. When quick responses to stimuli are needed, these kinases cannot be turned off by merely removing the phosphate groups that activated them and instead must rely on additional mechanisms to regulate their activity, such as inhibitory phosphorylations, binding of other regulatory proteins or rapid protein turnover (Lochhead et al., 2005) .
Trans-autophosphorylation
The conventional model of transautophosphorylation is that activation loop phosphorylation is mediated by one kinase transiently adopting an active conformation, thereby phosphorylating its neighbor (Figure 3) . The activated neighbor then becomes locked in the more permanent active conformation and reciprocally phosphorylates the first (Bae and Schlessinger, 2010; Oliver et al., 2007). However, this mechanism has inherent inefficiency due to the conformational instability of an unphosphorylated activation loop (Oliver et al., 2007) . It also assumes that the activation loop amino acids surrounding the important residue for phosphorylation match the kinase's consensus sequence for substrate phosphorylation, which is not always the case (Oliver et (Oliver et al., 2006) . The activation loop makes many hydrophobic contacts to residues of the opposite catalytic domain and buries a total of 2688 Å2 of surface area, but the activation loop must rearrange slightly to place T383 in proper orientation for phosphoryl transfer (Oliver et al., 2006; Wu et al., 1008). The structure of each subunit is considered active because all the necessary residues are spatially arranged for catalysis, the nucleotide binding site is accessible, the relative orientation of the N-and C-lobes are consistent with previous active structures and the activation loop is fully ordered (Oliver et al., 2006) . Whether Chk2 remains with swapped T loops after autophosphorylation or reverts back to activation Kimberly A. Malecka loops folded upon their own domains as seen in other active kinase structures remains unclear, however the authors note that phosphorylation of T168 that drives the dimerization places the catalytic domains in close contact with each other and allows for activation loops that do not match substrate consensus sequences to arrive in the active site, become autophosphorylated in trans, and activate the kinase (Oliver et al., 2006) . This is a process that is distinct from the method of true substrate phosphorylation (Oliver et al., 2006 These dimer structures suggest a mechanism of symmetrically swapped activation loops as a new model for trans-autophosphorylation ( Figure 3 ). Oliver speculates that it might be a common mechanism among kinases that rely on autophosphorylation, that dimerize either transiently or constitutively, and have amino acid sequences surrounding the crucial activation loop residue requiring phosphorylation that do not match the kinase's consensus sequence (Oliver et al., 2007) However, in 2011, a structure published by the laboratory of Zhi-Xin Wang suggested that Pak1's catalytic-activating autophosphorylation at T423 in its activation loop occurs via the conventional model (Wang et al., 2011) . Pak1 is a serine/ threonine kinase that exists as an inactive homodimer whose steric inhibition is released upon binding of the activated GTPases Rac1 or cdc42 and the phospholipid phosphatidylinositol 4,5-bisphosphate to the N terminal GTPase binding region and a basic motif, respectively. This kinase is known to play key roles in cytoskeletal dynamics (Arias-Romero and Chernoff, 2008; Table 1 . Key information for reviewed kinases. Each kinase discussed in this review is listed with the species studied and autophosphorylation mechanism listed. The necessary residues in the activation loop that need to be phosphorylated for kinase activation are listed. For those with more than one, the residues are listed in their sequential order. The human kinase group each studied kinase represents is also listed. For those studied in other organisms, the group corresponding to the human homologue is listed. For Ire1, yeast refers to Saccharomyces cerevisiae. . To activate its kinase activity, Ire1 autophosphorylates residues S840, S841 and T844 within its activation loop. This protein is also known to oligomerize. The reported crystal structure shows each subunit in the oligomer offering its activation loop to the preceding subunit's active site. Fascinatingly, each subunit acts both as enzyme and substrate.
Journal of Postdoctoral Research 2013: 41-55
As more kinase structural information becomes available, further unpredicted methods for enabling kinase autophosphorylation may be identified. Interestingly, even within those kinases that symmetrically exchange activation loops, their subunit interactions vary considerably.
For example, the DAPK3 dimerization subunits are less rotated with respect to each other than the subunits reported in IGF1R (Malecka and Peterson, 2011) . Kinases from several different branches of the human kinome undergo some form of activation loop exchange (either symmetric or asymmetric), which suggests that these broad models of trans-autophosphorylation may be common activation mechanisms (Table  1) (Oliver et al., 2007) .
Important questions remain about this type of autophosphorylation, however, including how the intermediates are resolved after phosphoryl transfer and what are the distinct functional roles of symmetric versus asymmetric trans-autophosphorylation (Malecka and Peterson, 2011) . . These types of assays also often overlook the importance of mono or diphosphorylated domains in inhibitor sensitivity differences (Table  1) , but only purvanol A is able to block dDYRK2 tyrosine autophosphorlyation following expression in rabbit reticulocyte lysate (Lochhead et al., 2005) . Similarly, a panel of known inhibitors of GSK3β's serine/threonine activity was screened and only a handful are found to block the intermediate, activating autophosphorylation of Y216 (Lochhead et al., 2006) . Thus, these kinases have two distinct catalytic activities that are separated not only by time but also by drug sensitivities (Lochhead et al., 2006) . Interestingly, after maturation of dDYRK2 and GSK3β in the presence of the translational intermediate inhibitors, the crucial tyrosine in the activation loop could not be phosphorylated, indicating that these inhibitors act irreversibly. Part of the reason that PKA was identified as a possible cis-autophosphorylating enzyme was because when the protein is expressed in the presence of its inhibitor H-89, catalytic domains are not phosphorylated at T197 and are unable to be phosphorylated later (Steinberg et al., 1993) . Not only does this work show that inhibition of the catalytic intermediates are possible and can be further studied, but also suggests that these kinases have inhibitors that are being missed by mining small molecule libraries with traditional highthroughput screening methods (Lochhead et al., 2006) .
Inhibition of Kinase Activation
Just as cis-autophosphorylation offers inventive inhibitor development ideas, so does transautophosphorylation. The dimeric and often faceto-face structures bring the ATP binding pockets in close proximity (Oliver et al., 2007; Oliver et al., 2006) . Double-headed, ATP-competitive inhibitors could be developed such that a linker would allow for both ATP binding pockets to be occupied simultaneously, thus increasing specificity of inhibitors. Such molecules have not been explored yet, but the theory has worked for ansamycin, which is a double-headed antiobiotic targeting two close ATP-binding domains in Hsp90 (Ali et al., 2006; Pearl and Prodromou, 2006) , and coumermycin A, a natural ATP-competitive antibiotic that binds and inactivates DNA gyrase B (Ali et al., 1993) .
Conclusion
The emerging mechanisms of cis-and transautophosphorylation begin answering the perplexing question of how the catalytically activating first phosphorylation can occur. Described here are two general methods for initial phosphorylating events among kinases that require autophosphorylated residues in their activation loops for catalytic activity. Interestingly, those kinases that subscribe to cisautophosphorylation carry out their mechanism in distinctly different ways: GSK3β requires Hsp90 while dDYRK2 and MNB do not (Figure 2) . The same variability is also noted among the transautophosphorylation kinases where Pak1 follows the conventional model while Chk2 conforms to the newer model. Even Chk2, SLK, LOK, DAPK3 and IGF1R, which all carry out the new model for trans-autophosphorylation, involve different interacting regions between the dimerized subunits ( Figure 3 ) (Malecka and Peterson, 2011) . Clearly no one-size-fits-all mechanism works for all kinases and it is doubtless that as more mechanisms are understood so will they uniquely fit into either of these two categories.
Few examples exist of crystallized protein kinase/ substrate complexes where substrates are longer than a few amino acids (Malecka and Peterson, 2011) .
Here, the trans-autophosphorylated kinases allow us to see that a variety of regions, including those distant from the active site, are involved in creating a stable complex for phosphorylation. For example, the Pak1 transautophosphorylation dimer structure that most resembles a traditional kinase/substrate relationship buries a total of 1600 Å2 with half of the interacting regions outside the enzyme's active site (Wang et al., 2011) . Even more interesting are the speculations to be made about how GSK3β, dDYRK2 and MNB fold up to have distinct phosphorylation activity separate from the final mature enzyme. The catalytic aspartate is known to be important to these three kinases (Lochhead et al., 2006; Lochhead et al., 2005) , but what other regions in the N and C terminal lobes, aside from the identified NAPA domain, are also necessary are still unknown as is what the actual intermediately folded kinase structurally looks like and how it differs from the properly folded ePK domain. Together, these mechanisms force us to step back from the kinase active site and consider the entire domain's involvement in initial activation as well as substrate phosphorylation.
All serine/threonine kinases and many tyrosine kinases fall within the RD kinase category, whose members often require the paradoxical activating phosphorylations within their activation loops for full catalytic activity. So far, only a handful protein kinases have their autophosphorylation mechanisms understood, but more will undoubtedly be studied and added to this growing field of kinase study. 
